Cécile Borel

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

M.L. Piel-Julian, Matthieu Mahévas, Johanne Germain et al. · Journal of Thrombosis and Haemostasis · 2018 · 136 citations · Full text

Medicine, Hematology, Immunology +15

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi, Julia Gilhodes, Marie Maerevoet et al. · American Journal of Hematology · 2018 · 122 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 99 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

Thierry Guillaume, Florent Malard, Léonardo Magro et al. · Bone Marrow Transplantation · 2019 · 98 citations

Medicine, Hematology, Oncology +17

Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy

K. Delavigne, E. Bérard, Sarah Bertoli et al. · Haematologica · 2013 · 93 citations · Full text

Medicine, Hematology, Oncology +16